Introduction
The number of prokaryotic protein glycosylation systems identified, both N-and O-linked, is increasing rapidly (Szymanski et al. 2003; Fletcher et al. 2009; Vik et al. 2009; Egge-Jacobsen et al. 2011) . Glycoproteins can be generated via glycosyltransferases in the cytoplasm or by an en bloc mechanism through the activity of oligosaccharyltransferases (OTases); enzymes that transfer a preassembled glycan from a lipid carrier to select amino acids in their target proteins in the periplasm . In bacteria, both N-and O-glycosylation can be carried out en bloc via an N-or an O-OTase, respectively (Hug and Feldman 2010) . The best characterized bacterial OTase is PglB, an N-OTase homolog to the eukaryotic Stt3, which is the key component of the OTase complex responsible for N-glycosylation in the lumen of the endoplasmic reticulum. In Campylobacter jejuni, PglB is responsible for the N-glycosylation of more than 60 periplasmic and membrane proteins (Szymanski and Wren 2005; . N-OTases seem to be common in many epsilons and in a few delta proteobacteria, particularly in the genus Desulfovibrio. N-OTases from different bacterial species appear to have particular sequence recognition sequences and diverse sugar specificities (Jervis et al. 2010; Ielmini and Feldman 2011; Schwarz et al. 2011) .
Two bacterial O-OTases have been well-characterized. PilO is responsible for O-glycosylation of a single protein, the type IV pilin, in several Pseudomonas aeruginosa strains (Castric 1995) . The O-OTases PglL from Neisseria meningitidis and PglO from N. gonorrhoeae are able to glycosylate multiple proteins (Faridmoayer et al. 2007; Ku et al. 2009; Vik et al. 2009; Borud et al. 2010) . PglO and PglL primary sequences differ only at a few sites, and for simplicity, this manuscript will use PglL Nm to refer to both enzymes. O-OTases share a conserved Pfam Wzy_C domain and a predicted similar membrane topology with the O-antigen ligase, WaaL, an enzyme involved in the attachment of O-antigen to lipid A during lipopolysaccharide (LPS) biosynthesis (Ruan et al. 2012 ). Due to these shared commonalities and the availability of only a few characterized O-OTases, current bioinformatic methods are unable to differentiate whether a particular gene encodes an O-antigen ligase or an O-OTase. Thus, the identification of O-glycosylation activity requires experimental demonstration.
The activities of both PilO and PglL have been reconstituted in Escherichia coli, where they exhibited very relaxed glycan specificity (DiGiandomenico et al. 2002; Faridmoayer et al. 2007 Faridmoayer et al. , 2008 . No requirements for specific stereochemistry or substitutions in the reducing sugar have been determined for glycan recognition to date. However, there is a difference in the length of the glycan that can be transferred; although PglL has no apparent length limit, PilO is only able to transfer short oligosaccharides (Faridmoayer et al. 2007 ). To date, there is also no determined consensus sequence for the acceptor protein, other than that it must encompass a serine or threonine residue. Particularly, PilO appears to only require a terminal serine residue (Qutyan et al. 2010) . It was proposed that PglL Nm recognizes "low-complexity regions (LCRs)" around the glycosylation site that includes an abundance of alanine, valine and proline residues, similar to what is found in the O-glycosylation sites of eukaryotes (Vik et al. 2009) . However, such a sequence is neither necessary nor sufficient for glycosylation. Although some requirements and properties have been described, the mechanism governing bacterial protein O-glycosylation remains largely unknown. Studying more of these enzymes from various bacterial systems will provide insight into the molecular basis of the O-glycosylation mechanism and may increase the already enormous potential of these enzymes for glycoengineering novel glycoproteins, which have promising applications in the vaccine design and as diagnostic tools (Feldman 2009; Iwashkiw et al. 2012) .
Here, we report the identification and characterization of two novel O-OTases encoded by VC0393 from Vibrio cholerae O1 El Tor N16961 and BTH_I0650 from Burkholderia thailandensis E264. The activity of these enzymes was assessed in a reconstituted system in E. coli. We found that each O-OTase has a specific glycan and acceptor protein requirements and that successful glycosylation depends upon a specific combination of protein acceptor, glycan and O-OTase.
Results
Identification of potential B. thailandensis and V. cholerae OTases O-OTases characterized to date have overall low sequence similarity. However, they share two main common features that can be used for their identification. These enzymes have the Pfam Wzy_C domain (PF04932) and are membrane proteins with at least 12 transmembrane domains (Power et al. 2006) . Using bioinformatic techniques that included BLASTP and BLASTX searches (Altschul et al. 1997) , hidden Markov modeling (Eddy 2009 ) and transmembrane profiling software, we identified open reading frames (ORFs) that could encode for WaaL ligases or O-OTases in both V. cholerae O1 El Tor N16961 (VC0237 and VC0393) and B. thailandensis E264 (BTH_I0988 and BTH_I0650). VC0237 has been functionally characterized as a true WaaL ligase, responsible for O-antigen transfer during LPS synthesis in V. cholerae (Schild et al. 2005) . Despite overall low sequence identities between themselves, VC0393 and BTH_I0650 could be distinguished from VC0237 and BTH_I0988 by virtue of a relatively extended C-terminus encompassing a DUF3366 domain that is also present in PglL Nm (Supplementary data, Figure S1 ). Interestingly, both proteins are well conserved within Vibrio and Burkholderia species (Supplementary data, Figures S2 and S3) . Therefore, we chose to focus further characterization on VC0393 and BTH_I0650.
VC0393 and BTH_I0650 have O-OTase activity
To determine if VC0393 and BTH_I0650 have O-OTase activity, the genes were cloned and the proteins expressed in E. coli with C-terminal polyhistidine tags. The VC0393 ORF consists of 597 residues and has a predicted mass of 67.4 kDa, whereas BTH_I0650 has 595 residues and a predicted molecular weight of 65 kDa. Expression of the proteins was analyzed by immunoblotting using anti-His-tag antibodies. VC0393 expression at 30°C resulted in significantly greater amounts of the protein than at 37°C, whereas the opposite was found for BTH_I0650 (Supplementary data, Figure S4A and B).
To test the functionality of an OTase in E. coli, the enzyme has to be co-expressed with an appropriate protein acceptor and a glycan donor (Feldman et al. 2005) . Flagellin glycosylation has been reported in B. pseudomallei (Scott et al. 2011) . However, there is no evidence of an en bloc glycosylation system in V. cholerae or Burkholderia spp. reported to date. Consequently, no information about possible native protein acceptors or glycan donors was available. It was previously shown that the lipid-linked heptasaccharide from C. jejuni (CjLLO) can serve as a successful glycan donor for several N-and O-OTases, including PglL Nm and PilO (Faridmoayer et al. 2007; Ielmini and Feldman 2011) . We speculated that it could also act as a substrate for the putative V. cholerae and B. thailandensis OTases analyzed. As potential protein acceptors, we chose three well-characterized O-linked glycoproteins; the type IV pilin subunit protein from N. meningitidis MC58 (Power et al. 2006) , the Laz (lipid-azurin) protein from N. gonorrhoeae (Vik et al. 2009 ) and the disulphide isomerase DsbA1 protein from N. meningitidis MC58 (Lafaye et al. 2009 ). The corresponding genes were cloned and expressed in E. coli as C-terminal His-tagged proteins.
To test the OTase activity of the V. cholerae and B. thailandensis ORFs, plasmids expressing one of the putative OTases and one of the three protein acceptors ( pilin, Laz or DsbA1) were co-transformed into E. coli strain CLM24 carrying a plasmid that contained the C. jejuni pgl genes required for the O-Oligosaccharyltransferases from Vibrio and Burkholderia synthesis of the CjLLO. The CLM24 strain is a convenient system for glycosylation studies, because the absence of WaaL results in the accumulation of the Und-PP-linked glycans that serve for OTase substrates (Feldman et al. 2005) . In our experiments, we included the previously characterized OTase PglL Nm from N. meningitidis MC58 for comparison purposes. Whole-cell lysates were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed by western blot using an infrared fluorescent imaging system. This system allows the simultaneous detection of two different molecules ( protein and glycan) in separate fluorescent channels: red and green. Co-localization of both signals is visualized in yellow, which allows the detection of modifications to proteins in the same membrane. Western blot analysis was performed using the polyclonal anti-glycan HR6 antibody for detection of the C. jejuni heptasaccharide and monoclonal anti-His antibody to detect the His-tagged recombinant proteins.
All the three acceptor proteins tested in the presence of VC0393 exhibited a slower migrating band compared with each unmodified protein control that was reactive toward both antibodies (Figure 1 ). The electrophoretic shift noticed was compatible with the addition of the CjLLO to each protein. This suggested that VC0393 was able to transfer the CjLLO to the three acceptor proteins tested. In a parallel experiment, BTH_I0650 transferred the oligosaccharide only to Laz and Fig. 1 . O-OTases BTH_I0650 and VC0393 transfer a heptasaccharide to specific protein acceptors. Whole-cell lysates of E. coli CLM24 cells expressing pilin (A), Laz (B) or DsbA1 (C) as acceptor proteins together with CjLLO and different O-OTases were separated by SDS-PAGE and analyzed by western blotting. His-tagged proteins were detected using the monoclonal anti-His antibody (green). The CjLLO glycan was detected using the polyclonal HR6 antibody (red). The overlapping signals are shown in yellow (merge). The glycosylation of pilin by PglL Nm has been shown elsewhere (Faridmoayer et al. 2007) . Some bands corresponding to unspecific binding of the antibodies or E. coli protein glycosylated with the heptasaccharide can be seen in panels B and C. Figure 1C , lower panel). More than one band reacting with both the anti-glycan and the anti-His antibodies were detected for this acceptor protein. These bands likely reflect the glycosylation of two different forms of DsbA1, possibly resulting from proteolytic degradation or incomplete processing of the lipoprotein.
Mapping the glycosylation sites of DsbA1 glycopeptides
Western blot analysis indicated that DsbA1 was glycosylated by all three OTases with the glycan tested. Given the potential use of this protein for biotechnological applications, we wanted to further confirm the glycosylation results observed by western blot and to determine the precise glycosylation site(s) on this protein by mass spectrometric (MS) analysis. DsbA1 glycosylated with the C. jejuni heptasaccharide by PglL Bt was purified using a Triton X-114 phase separation method optimized for the purification of lipoproteins (Supplementary data, Figure S5 ), followed by affinity nickel chromatography. The purified glycosylated DsbA1 was subjected to SDS-PAGE and visualized by Coomassie staining. The same sample was also analyzed by western blot revealing four bands corresponding to unglycosylated and three glycosylated forms of DsbA1 ( Figure 2A ). These bands were processed by proteolytic in-gel digestion with trypsin and the peptide mixture was analyzed by MS. Previous work on N. gonorrhoeae DsbA1 homolog demonstrated that this protein is glycosylated by PglL Nm in an LCR at the N-terminal part of the protein (Vik et al. 2009 The difference between these set of ions is 1381 Da, which could corresponds to the mass of a (HexNAc) 6 Hex moiety, one of the glycosylation forms of the CjLLO synthesized in E. coli, containing N-acetylglucosamine (HexNAc) instead of the 2,4-di-N-acetylbacillosamine (diNAcBac) produced in the original host (Wacker et al. 2002; Reid et al. 2009 ). The identity of the attached glycan was confirmed by β-elimination of the O-linked glycans followed by permethylation and MALDI-MS and MS/MS analysis ( Figure 3 ). The highresolution MALDI-MS spectrum showed a peak at 1743.88888 Da corresponding to an elemental composition of C 77 H 136 N 6 O 36 + Na with a mass error of -0.05 ppm, which corresponds to the above-mentioned glycan moiety. A sequence of the glycan moiety has also been confirmed by MS/ MS analysis. Similar results were obtained when glycosylated samples of DsbA1 by PglL Vc were analyzed (data not shown). Together, these data provided strong evidence that both OTases recognize and glycosylate a site located in the same LCR in the N-terminal part of the protein, in agreement with the findings previously reported for PglL Nm .
Glycan donor specificity of PglL Bt and PglL Vc
To test if PglL Vc and PglL Bt also present relaxed glycan specificity, we compared their ability to transfer mono-and polysaccharides to the protein acceptors. Monosaccharides are not transferred by the N-OTase PglB (Schwarz et al.) . We tested if the undecaprenyl pyrophosphate attached to the monosaccharide diNAcBac could serve as a glycan donor. This sugar was chosen because glycosylation can be easily detected by western blot using a specific monoclonal antibody (mAb) that recognizes a diNAcBac-associated epitope. Moreover, diNAcBac is found as the reducing sugar in several glycans present in N-glycoproteins from C. jejuni and O-glycoproteins from Neisseria spp. (Young et al. 2002; Power and Jennings 2003) . Whole-cell lysates of the E. coli strain CLM24 expressing one OTase, one of the protein acceptors and carrying the N. gonorrhoeae pglFBCD genes, sufficient for the synthesis of lipid-linked diNAcBac, were separated by SDS-PAGE and analyzed by western blot. The addition of a monosaccharide does not significantly change the electrophoretic mobility of the glycoproteins relative to the unglycosylated control. However, glycosylation can be detected as an overlapping signal, visualized in yellow, between the protein and glycan signals. As is shown in Figure 4 , PglL Nm and PglL Vc were able to transfer diNAcBac to pilin and DsbA1, but not to Laz, whereas PglL Bt transferred the monosaccharide only to Laz and DsbA1. It was surprising to find that although the three OTases were able to efficiently transfer diNAcBac to DsbA1, the transfer of this monosaccharide to Laz was inefficient. Both PglL Vc and Pgl Bt glycosylated Laz with the CjLLO; therefore, Laz contains all the information required for recognition by this OTase. Furthermore, these results indicate that certain combinations of sugars and proteins result in productive interactions, whereas other combinations do not produce glycosylation. Interestingly, pilin is not a substrate of PglL Bt but it is recognized by PglL Vc and Pgl Nm , , whereas Laz is a substrate of PglL Vc and PglL Bt . This indicates that these OTases do not recognize the same structural determinants in the acceptor proteins.
PglL Bt and PglL Vc can transfer polysaccharides
The ability of PglL Bt and PglL Vc to glycosylate DsbA1 with both mono-and oligosaccharides prompted us to test if these enzymes could also transfer polysaccharides to the acceptor proteins, a property that may be relevant for glycoengineering purposes. The E. coli K12 strains naturally expresses the O16 O-antigen, which has been shown to be a substrate for PglL Nm (Faridmoayer et al. 2008) . However, all the common lab strains, including CLM24, have an insertion in the rhamnosyltransferase (WbbL) gene, which is essential for O16-antigen biosynthesis. Plasmid pMF19, encoding WbbL, restores the synthesis of this polysaccharide (Feldman et al. 1999) . Escherichia coli CLM24 cells expressing DsbA1 were O-Oligosaccharyltransferases from Vibrio and Burkholderia transformed with pMF19 and either pCDG10 ( pglL Bt ) or pCDG4 ( pglL Vc ). Glycosylation of DsbA1 with the E. coli O16 polysaccharide was analyzed using a polyclonal anti-O16 antibody. The typical pattern of bands corresponding to protein attached to O-antigen was detected with both the anti-His antibodies and anti-O16 antibodies, indicating that PglL Bt was able to glycosylate DsbA1 with fully polymerized E. coli O16 antigen ( Figure 5) . A band of a molecular mass compatible in size with PglL Vc was visualized with anti-His antibody only in cells expressing PglL Vc in the absence of O-antigen ( Figure 5 , middle panel). Interestingly, PglL Nm and PglL Vc were unable to transfer the polysaccharide to DsbA1. This was unexpected, because PglL Nm is able to glycosylate pilin with the same polysaccharide.
PglL Vc can glycosylate itself Carbohydrate-specific staining methods failed to show evidence of PglL Vc activity in V. cholerae (data not shown). To identify the possible endogenous glycosylation substrates, we transformed V. cholerae cells with plasmid pCDG4 ( pglL Vc ) and pEF33 (contains the enzymes to synthesize lipid-linked diNAcBac). Only one band matching the expected electrophoretic mobility of PglL Vc was detected with the anti-glycan antibody in the presence of both the OTase and the glycan ( Figure 6A ). This band was also detected with the anti-His antibodies, suggesting that PglL Vc was glycosylated. To confirm this hypothesis, PglL Vc was purified by affinity nickel chromatography. The purified protein was subjected to SDS-PAGE and visualized by Coomassie staining. The band was in-gel digested with trypsin and the peptide mixture was analyzed by LC-ESI-QTOF-MS/MS ( Figure 6B) .
The MS/MS results identified a triply charged peak detected at m/z 749.63 Da having the peptide sequence of O-Oligosaccharyltransferases from Vibrio and Burkholderia VNSATSDAEVPSAATPHH with two diNAcBac residues attached to it. This peptide is located at the C-terminal end of PglL Vc and also contains two of the histidine residues derived from the His-tag. This result demonstrated that PglL Vc contains the molecular determinants necessary for glycosylation and that in the presence of a suitable glycan donor, it can selfglycosylate. This analysis does not rule out the possibility that other proteins, present in minor amounts, are also glycosylated, but not detected in these conditions.
Discussion
Most of the bacterial OTases described so far exhibit relaxed glycan specificity. This feature makes bacterial OTases useful tools for glycoengineering of novel glycoconjugates with promising applications in vaccinology and diagnostics. The identification and study of additional OTases may result in novel and more efficient enzymes, which could have distinct biotechnological applications. It has been proposed that bacterial glycoproteins could constitute a novel generation of conjugate vaccines (Feldman et al. 2005; Feldman 2009 ). Recently, promising applications of bacterial engineered glycoproteins for the diagnostics of bacterial infections have been demonstrated (Iwashkiw et al. 2012) . The first OTases characterized were C. jejuni PglB N-OTase and multiple related ε-proteobacteria homologs (Szymanski et al. 1999; Wacker et al. 2002 Wacker et al. , 2006 Kowarik et al. 2006; Jervis et al. 2010; Schwarz et al. 2011) . Although initially it was assumed that all bacterial PglB homologs will recognize the same protein acceptor sequence DxNxS/T, it was established that PglB from the δ-proteobacterium Desulfovibrio desulfuricans recognizes a different sequence in its target protein (Ielmini and Feldman 2011) . O-Glycosylation seems to be more widespread among bacteria. However, the activities of only three Fig. 4 . PglL Bt and PglL Vc can glycosylate different acceptor proteins with the monosaccharide diNAcBac. Whole-cell lysates of E. coli CLM24 cells expressing pilin (A), Laz (B) or DsbA1 (C) as acceptor proteins together with diNAcBac ( pEF33) and different O-OTases were separated by SDS-PAGE and analyzed by western blotting. His-tagged proteins were detected using the monoclonal anti-His antibody. The diNAcBac glycan was detected using the antibody npg2.
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O-OTases have been conclusively demonstrated. These are P. aeruginosa PilO, Neisseria PglL and Francisella tularensis PglA (Castric 1995; Faridmoayer et al. 2007; Egge-Jacobsen et al. 2011 ). The acceptor sequences and glycan specificities of PilO and PglL are different. PilO does not transfer polysaccharides and recognizes a sequence located at the C-terminal of the protein (Qutyan et al. 2010) . Although PglL can transfer polysaccharides of virtually any glycan structure to the pilin protein, the acceptor requirements have not been conclusively elucidated (Faridmoayer et al. 2008) . Several acceptor proteins, but intriguingly not the pilin protein, are glycosylated at LCRs, rich in S, A and P (Vik et al. 2009 ). For some of the remaining O-glycosylation systems described, like the ones present in Bacteroides fragilis and Tannerella forsythia, the acceptor sequence is known to be D-(S/T)-(A/I/L/M/T/V), but the O-OTases involved remain elusive (Fletcher et al. 2009; Posch et al. 2011) . In other cases, like P. aeruginosa TfpW, the OTase activity remains to be experimentally demonstrated (Kus et al. 2008) .
In this work, through their active expression in E. coli, we have shown that the genomes of B. thailandensis and V. cholerae encode O-OTases. Both novel OTases are present in bacteria where no glycosylation systems have been reported previously, and therefore their native substrates were unknown. However, the OTase activity could be analyzed using proteins that are known substrates of PglL Nm , which demonstrates that the three enzymes are able to recognize and glycosylate the same motifs. This is supported by the MS results that map the glycosylation site on the acceptor protein DsbA1 used by PglL Vc and PglL Bt at the same region previously described for PglL Nm .
Pilin, Laz and DsbA1 were glycosylated by PglL Vc with the CjLLO, which demonstrates that these three protein substrates carry the molecular determinants recognized by this OTase. PglL Vc was also capable of transferring a monosaccharide, diNAcBac, to two of these proteins, pilin and DsbA1, indicating that the enzyme can utilize the lipid-linked diNAcBac donor molecule. However, PglL Vc failed to glycosylate Laz, with only diNAcBac, which means that although Laz and diNAcBac can be substrates in the presence of a different sugar or acceptor protein, they cannot be effectively linked by this enzyme. Similarly, PglL Nm was able to use DsbA1 as a Fig. 5 . Glycosylation of DsbA1 with the E. coli O16 O-antigen (EC O16). Western blot analysis of whole-cell lysates of E. coli CLM24 cells expressing the indicated plasmids: DsbA1, pAMF22; EC O16, pMF19; PglL Bt , pCDG10; PglL Vc , pCDG4; PglL Nm , pAMF10. Each glycosylation experiment included as controls conditions with no protein acceptor ( pMLBAD for DsbA1), no glycan donor ( pEXT21) and no OTase ( pEXT20). His-tagged proteins were detected using the monoclonal anti-His antibody (A). EC O16 was detected by the polyclonal anti-O16 antibody (B).
O-Oligosaccharyltransferases from Vibrio and Burkholderia substrate with diNAcBac and the CjLLO, but was unable to transfer the E. coli O16 polysaccharide, a known substrate for this enzyme when pilin is the acceptor protein. Therefore, it appears that O-OTases require a specific combination of protein and glycan structures for a productive interaction resulting in glycosylation. It is tempting to speculate that one of the substrates binds first to the enzyme causing a conformational change, which in turn may impose certain steric constraints that will allow the second substrate to productively reach the catalytic site. This finding has relevance for glycoengineering purposes, as some glycan structures of interests may be efficiently attached to certain carriers, but not to others.
The presence of active O-OTases in the genomes of both B. thailandensis E264 and V. cholerae O1 El Tor N16961 demonstrates that these strains have the potential to express glycosylation systems. It remains unclear if such activities are indeed functional in the native backgrounds. It is interesting to note that in V. cholerae, pglL Vc maps near mshA, the gene for the major component of one of the type IV pilin that this bacterium expresses, whereas in B. thailandensis and other Burkholderia species, pglL Bt and orthologous genes map immediately adjacent to pilA, encoding a likely type IV pilus protein. We have attempted to glycosylate MshA and B. thailandensis pilin in E. coli using strategies employed to glycosylate the Neisseria proteins, but these efforts were unsuccessful. However, introduction of an inducible plasmid expressing PglL Vc and lipid-linked diNAcBac biosynthetic genes under a constitutive promoter into V. cholerae showed Fig. 6 . PglL Vc glycosylates itself. (A) Whole-cell lysates of V. cholerae expressing PglL Vc and diNAcBac were separated by SDS-PAGE and analyzed by western blotting. His-tagged proteins were detected using the polyclonal anti-His antibody and the diNAcBac glycan was detected using the polyclonal antibody UOS-2. (B) Analysis of the deconvoluted spectrum of a triply charged peak detected at m/z 749.63 Da positively identified the peptide sequence of VNSATSDAEVPSAATPHH with two diNAcBac residues attached to it. The spectrum shows an almost complete series of y-type, some b-type peptide fragment ions along with strong peaks for the peptide only at m/z 1790.7 Da and peptide with one diNAcBac attached at m/z 2018.9 Da. The difference between the peak at 2018.9 Da and the molecular ion at m/z 2247.0 Da demonstrates the attachment of a second diNAcBac. No peaks within the spectrum were found to shows the exact location of the attached glycan residues. The presence of diBacNAc residues is also confirmed by the presence of the fragment ions detected at m/z 229.1, 211.1 and 169.1 Da, as reported previously (Chamot-Rooke et al. 2007 ).
C Gebhart et al. that in the presence of a suitable lipid-linked sugar, PglL Vc can self-glycosylate. Interestingly, the peptide glycosylated in PglLVc, as most of the acceptor sequences shown for PglL, contains multiple S, A and P residues. The high degree of conservation of the O-OTases in different Vibrio and Burkholderia species may be taken as an indication of the existence of a strong evolutionary pressure to retain the O-OTases in the genomes of these strains. These results prompt us to speculate that O-glycosylation in these strains is a highly regulated process, which may occur only under certain environmental conditions. In this context, it is important to recall that Vibrio and Burkholderia species also express O-polysaccharides that are dependent on WaaL ligases and pathways that parallel to those of protein O-glycosylation. Such regulation might be required to coordinate these processes so as to mitigate potential biosynthetic and metabolic cross-talk or incompatibilities. However, strains of F. tularensis subsp. tularensis simultaneously express WaaL-dependent, O-polysaccharide modified LPS and O-OTase-dependent protein glycosylation systems (Egge-Jacobsen et al. 2011) . Future work will be required to determine if and when protein O-glycosylation occurs in these species.
The number of bacterial species known to carry O-linked protein glycosylation is rapidly increasing. It is now clear that many bacterial pathogens are able to O-glycosylate proteins. The involvement of O-glycosylation in bacterial pathogenesis remains unknown. It will be interesting to test if glycosylation plays a role in pathogenesis of V. cholerae or Burkholderia spp., since glycoproteins could also play a role in biofilm formation. The discovery of PglL Vc and PglL Bt enlarges the repertoire of enzymes available for glycoengineering, which irrespective of the role played by glycosylation in bacterial physiology and/or pathogenesis, and may contribute to the design of novel and improved diagnostics tools and conjugate vaccines against bacterial infections.
Materials and methods

Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed in Table I . Escherichia coli and V. cholerae strains were grown overnight on Luria-Bertani broth at 37 and 30°C, respectively. Trimethoprim (Tp, 100 μg/mL), tetracycline (Tet, 20 μg/mL), spectinomycin (Sp, 80 μg/mL), chloramphenicol (Cm, 20 μg/mL), kanamycin (Km, 50 μg/mL), streptomycin (Sm, 200 μg/mL) and ampicillin (Amp, 100 μg/mL) were added to the medium as require Plasmid Construction.
Genomic DNA was isolated using the DNeasy Blood & Tissue kit (Qiagen Inc., Canada). Plasmid DNA was isolated with either the QIAprep Spin Miniprep Kit (Qiagen Inc., Canada) or the QIAGEN Plasmid Midi Kit (Qiagen Inc., Canada). The vc0393 gene encoding the O-OTase of V. cholerae O1 El Tor N16961 was amplified by polymerase chain reaction (PCR) with oligonucleotides PglLF01 (5′-ATA GAA TTC ATG AAC TGC ATG GCA ACT TTG CTG TTA AGT GGC ACT CGG TTG G-3′) and PglLR01 (5′-ATA AAG CTT TTA GTG GTG GTG GTG GTG GTG GGG TGT CGC GGC TGA GGG AAC CTC AGC ATC AGA TGT GG-3′) using the Vent DNA polymerase (New England Biolabs Table I . Bacterial strains and plasmids used in this study
Strains and plasmids Description
Reference or source Escherichia coli Top10 mcrA, Δ(mrr-hsdRMS-mcrBC), ΔlacX74, deoR, recA1, araD139 Δ(ara-leu)7697, galK, rpsL, endA1, nupG O-Oligosaccharyltransferases from Vibrio and Burkholderia (NEB), Canada) and V. cholerae O1 El Tor N16961 genomic DNA as a template. The resulting PCR product was digested with EcoRI and HindIII and inserted into the same sites of the cloning vector pSPORT1 to generate pCDG2 (Table I) . To obtain Vc0393 on an inducible plasmid, pCDG2 was cut with EcoRI and HindIII and inserted into the same sites of the highcopy cloning vector pEXT20 to generate pCDG4 (Table I) .
To obtain a plasmid expressing the O-OTase of B. thailandensis E264 under an IPTG-inducible promoter, the bth_i0650 gene was amplified from the pEF186 (Table I) plasmid with the primers BTH_BamHI_FW (5′-TAT GGG ATC CAT GCC TTC CTC TTT TCT GCG TTC TTT ATC GCT GAT CG-3′) and BTH_HindIII_6HIS_RV (5′-TTT AAG CTT TCA GTG GTG GTG GTG GTG GTG TTC GTC GCT GTC GTC TTC CTC GTC GTC GGC GGA CAG G-3′) using the Vent DNA polymerase. The purified amplicon was digested sequentially with BamHI then HindIII and inserted into the same sites of pEXT20 to generate pCDG10 (Table I) . Similarly, to obtain a plasmid expressing NGO0994 (Laz) under an IPTG-inducible promoter, the plasmid pMRM1 was digested with SalI-HF and XbaI and inserted into the same sites of the low-copy cloning vector, pEXT21, to generate pLaz1 (Table I ).
In vivo protein glycosylation All protein glycosylation reactions were carried out in the E. coli strain CLM24 transformed with three plasmids containing the desired protein acceptor, O-OTase and glycan biosynthetic machinery. Cells containing PglL Bt were cultured at 37°C, whereas those containing PglL Vc or PglL Nm were cultured at 30°C. Cells were grown to an optical density at 600 nm of 0.4-0.6 before induction with 0.1 mM IPTG and/or 0.2% arabinose, when appropriate. Those cultures requiring arabinose induction had an additional dose added after a minimum of 4 h of induced growth. Whole-cell lysates were harvested at a stationary phase. Glycosylation efficiency was determined by western blot analysis.
SDS-PAGE, Coomassie and western blot analysis
Glycoproteins obtained from whole-cell lysates were separated with 12% SDS-PAGE gels, using the standard protocols. All samples were loaded at a concentration of 0.1 OD. Separated glycoproteins were either transferred to nitrocellulose for detection with western blotting or immediately visualized with Coomassie blue staining. Primary and secondary antibodies used in this study are listed in Supplementary data, Table S2 . Membranes were visualized using the Odyssey ® Infrared Imaging System (Li-Cor Biosciences, USA), which allows for direct IR fluorescence detection at 685 and 785 nm simultaneously. Hence, the same membrane can be blotted with polyclonal antibody and mAb at once, allowing for simple confirmation of overlapping signals.
Purification of glycosylated DsbA1
Purification of the 6× His-tagged glycosylated lipoprotein, DsbA1, was adapted from previously published protocols (Hasebe et al. 2004; Thakran et al. 2008) . Briefly, 2 L of E. coli CLM24 cells expressing pAMF22, pCDG10 or pCDG4 and pACYCPglB mut were cultured for glycosylation as described above in in vivo protein glycosylation section. Cultures were induced with IPTG (0.1 M) and arabinose (0.2%). Bacterial cells were harvested during stationary phase at 5000 × g for 15 min at 4°C and were washed with phosphate-buffered saline (PBS). Resulting bacterial pellets resuspended in a ratio of 1 g of pellet to 10 mL of buffer #1 (1 μg/mL DNase I, complete EDTA-free protease inhibitor cocktail, 2% Triton X-114 in PBS). Lysis was allowed to occur during incubation on ice for 4 h. Cellular debris was removed by centrifugation at 10,000 × g for 10 min at 4°C. The supernatant was incubated at 37°C for a minimal time to induce phase separation. The aqueous phase was removed after centrifugation at 10,000 × g for 10 min at 30°C. The remaining detergent layer containing the glycosylated lipoproteins was diluted to the original solution volume with buffer #1 without detergent. Ice incubation and aqueous phase removal were repeated twice, although the ice incubation was reduced to 1 h. To the detergent phase, 10 mM imidazole and 300 mM NaCl were added prior to the addition of an appropriate volume of 50% nickel-nitrilotriacetic acid (Ni-NTA) resin equilibrated in buffer #2 (2% Triton X-114, and 30 mM NaCl in PBS). This solution was allowed to mix overnight at 4°C. The Ni-NTA resin was packed and then washed three times with buffer #2 containing 50 mM imidazole. Desired His-tagged lipoproteins were eluted twice with buffer #2 containing 300 mM imidazole and were concentrated by TCA precipitation.
In-gel protein digestion
In-gel enzymatic digestion for Coomassie blue stained glycosylated and unglycosylated DsbA1 bands was done as published previously (Shevchenko et al. 1996) , with the following modifications. Briefly, purified, glycosylated DsbA proteins were run on a 12% SDS-PAGE gel and stained with Coomassie blue. Cysteine bonds were reduced by treatment with 10 mM DTT in 50 mM ammonium bicarbonate for 1 h at 37°C. Thiol groups were alkylated with 50 mM iodoacetamide in 50 mM ammonium bicarbonate at room temperature for 1 h. Following subsequent washing, peptides were digested with the protease, trypsin (Promega, USA; 0.02 mg/ mL of 50 mM ammonium bicarbonate) for at least 16 h at 37°C. Peptide fragments were eluted from the gel slices using acetonitrile (100%) and lyophilized. Salts were removed from the peptides using ZipTipC18 (Millipore, USA) according to the manufacturer's instructions. Desalted peptides were dried by Speed-Vac, dissolved in 0.1% formic acid and used for subsequent MS analyses. Alternatively, dried samples were subjected to β-elimination and glycan permethylation for detailed glycan MS analyses, as described below.
β-Elimination and glycan permethylation
The β-elimination reactions were done according to a previously published protocol (Goetz et al. 2009 ). Briefly, 1 μL of 5 μg/μL ammonia-borane complex in 28% ammonium hydroxide was added to 1 μg of lyophilized glycoprotein solution prepared as above and incubated for 24 h at 60°C. Cooled solutions were neutralized with 1 M hydrochloric acid. Dried samples were repeatedly resuspended in 100 μL of methanol (100%) and lyophilized for three times. Released glycans were permethylated according to the published protocols (Kang et al. 2008; Alley et al. 2010) . Briefly, NaOH beads were resuspended in acetonitrile and loaded onto SpinColumnTM reactors (Harvard Apparatus, USA). Beads were washed with dimethylformamide (DMF). Dried glycans were solubilized in 100 μL of 70:25:5% DMF:iodomethane: water solution. This solution was loaded onto the NaOH beads in the spin column and incubated for 15 min at room temperature. To ensure that all glycans had bound to the beads, an additional 25 μL of iodomethane was added and allowed to incubate for an additional 15 min. Spin columns were washed twice with 100 μL of acetonitrile. Glycan samples were recovered by liquid/liquid extraction and added to a glass vial containing 300 μL of dichloromethane. To this, 1 mL of 0.5 M sodium chloride was added to separate the organic and aqueous phases. The aqueous phase was removed and phase separation was repeated two additional times. Samples were washed with HPLC grade water three times and then lyophilized. Dried samples were resuspended in a 75:25 solution of methanol to water prior to being spotted on the MALDI plates needed for MS analysis.
MALDI-MS and MS/MS analysis
Desalted samples were spotted on an MTP AnchorChipTM 600/ 384 target plate and air dried. A 0.5-µL aliquot of a 10-mg/mL solution of 2,5-dihydroxybenzoic acid (Burker Daltonics Ltd., Canada) prepared in 70% acetonitrile and 30% Optima LC-MS Grade H 2 O (Fisher, Canada) was spotted on the MALDI plate for MALDI analysis. The MALDI-TOF MS and MS/MS mass spectra were obtained on an UltrafleXtreme MALDI TOF/TOF mass spectrometer (Bruker Daltonics, Germany). The analyzer was used in the reflectron mode of operation. Calibration was done externally using a mixture of standard peptides. The peptide ion peak picking and mass assignments were done automatically using the peak picking software of the system. The high-resolution MALDI-MS spectrum of the permethylated glycan was obtained using a Bruker 9.4T Apex-Qe FTICR (Bruker Daltonics, USA). Calibration was done externally using a sodium cationized polyethylene glycol.
Supplementary data
Supplementary data for this article is available online at http ://glycob.oxfordjournals.org/. 
